眼科远程医疗发展现状与前景

张潇; 陈有信

doi:10.12290/xhyxzz.2021-0198

眼科远程医疗发展现状与前景

doi: 10.12290/xhyxzz.2021-0198

张潇,
陈有信^,

基金项目:

中国医学科学院中央级公益性科研院所基本科研业务费专项基金 2018PT32029

详细信息

通讯作者:
陈有信电话：010-69156351，E-mail：chenyouxinpumch@163.com

中图分类号: R770.4; TP18
计量
- 文章访问数: 277
- HTML全文浏览量: 298
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2021-02-17
- 录用日期: 2021-04-21
- 网络出版日期: 2021-11-26
- 发布日期: 2021-09-01
- 刊出日期: 2021-09-30

Current Situation and Prospect of Teleophthalmology

ZHANG Xiao,
CHEN Youxin^,

Funds:

The Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2018PT32029

More Information

Corresponding author: CHEN Youxin Tel: 86-10-69156351, E-mail: chenyouxinpumch@163.com

摘要

摘要: 随着技术的进步，医生可通过远程医疗进行疾病的诊断和治疗。目前眼科远程医疗主要用于某些眼科疾病的筛查和诊断、慢性眼病的监测，以及眼科疾病的远程会诊等。随着眼科远程医疗的需求及应用不断增加，逐渐暴露出存在的一些问题，如基础设施和人员配备、医疗风险、患者接受度和满意度、网络安全和隐私保护、医疗保险覆盖等。COVID-19疫情全球大流行将远程医疗推向了眼科医疗服务的前沿，并可能持续改变眼科疾病的诊疗模式。随着人工智能技术的发展、5G通信网络覆盖范围的扩大、基层医疗服务人员培训的规范化及相关法律法规的出台，眼科远程医疗将更加规范和完善，应用范围更加广泛，为患者提供高质量、可持续性的医疗服务。
- 眼科远程医疗 /
- 糖尿病视网膜病变 /
- 早产儿视网膜病变 /
- 青光眼 /
- 年龄相关性黄斑变性 /
- 人工智能
Abstract: With the development of technology, doctors can diagnose and treat many diseases through telemedicine. At present, teleophthalmology is mainly used in screening and diagnosing some ocular diseases, monitor-ing chronic ocular diseases, as well as teleconsultation. With the increasing demand and application of teleophthalmology, some problems will gradually become prominent, such as insufficient equipment and staff, medical risks, patient acceptance and satisfaction, network security, privacy, and covering of medical insurance. The global pandemic of COVID-19 has unexpectedly brought telemedicine to the forefront of ophthalmic services, and may continue to change the way of ophthalmic diagnosis and treatment. With the development of artificial intelligence technology, the expansion of 5G communication network coverage, the standardized training of primary medical staff, and the introduction of relevant laws and regulations, teleophthalmology will become more improved, universal, and widely applied, so as to provide patients with sustainable medical services of higher quality.
- teleophthalmology /
- diabetic retinopathy /
- retinopathy of prematurity /
- glaucoma /
- age-related macular degeneration /
- artificial intelligence

HTML全文

参考文献(39)

[1]	Dorsey ER, Topol EJ. State of Telehealth[J]. N Engl J Med, 2016, 375: 154-161. doi: 10.1056/NEJMra1601705
[2]	Parikh D, Armstrong G, Liou V, et al. Advances in Telemedicine in Ophthalmology[J]. Semin Ophthalmol, 2020, 35: 210-215. doi: 10.1080/08820538.2020.1789675
[3]	Hadziahmetovic M, Nicholas P, Jindal S, et al. Evaluation of a Remote Diagnosis Imaging Model vs Dilated Eye Examination in Referable Macular Degeneration[J]. JAMA Ophthalmol, 2019, 137: 802-808. doi: 10.1001/jamaophthalmol.2019.1203
[4]	Grau E, Horn F, Nixdorff U, et al. OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257: 2571-2578. doi: 10.1007/s00417-019-04457-1
[5]	Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition[J]. Diabetes Res Clin Pract, 2019, 157: 107843. doi: 10.1016/j.diabres.2019.107843
[6]	Yau JW, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35: 556-564. doi: 10.2337/dc11-1909
[7]	Wong TY, Sabanayagam C. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence[J]. Ophthalmologica, 2020, 243: 9-20. doi: 10.1159/000502387
[8]	Scotland GS, McNamee P, Fleming AD, et al. Scottish Diabetic Retinopathy Clinical Research Network. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy[J]. Br J Ophthalmol, 2010, 94: 712-719. doi: 10.1136/bjo.2008.151126
[9]	Nguyen HV, Tan GS, Tapp RJ, et al. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore[J]. Ophthalmology, 2016, 123: 2571-2580. doi: 10.1016/j.ophtha.2016.08.021
[10]	Horton MB, Brady CJ, Cavallerano J, et al. Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition[J]. Telemed J E Health, 2020, 26: 495-543. doi: 10.1089/tmj.2020.0006
[11]	Fonda SJ, Bursell SE, Lewis DG, et al. The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management[J]. Telemed J E Health, 2020, 26: 1466-1474. doi: 10.1089/tmj.2019.0281
[12]	Ting DSW, Cheung CY, Lim G, et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes[J]. JAMA, 2017, 318: 2211-2223. doi: 10.1001/jama.2017.18152
[13]	Trese MT. What is the real gold standard for ROP screening?[J]. Retina, 2008, 28: S1-S2. doi: 10.1097/IAE.0b013e31816a5587
[14]	Brady CJ, D'Amico S, Campbell JP. Telemedicine for Retinopathy of Prematurity[J]. Telemed J E Health, 2020, 26: 556-564. doi: 10.1089/tmj.2020.0010
[15]	Shah PK, Ramya A, Narendran V. Telemedicine for ROP[J]. Asia Pac J Ophthalmol (Phila), 2018, 7: 52-55.
[16]	Li JO, Liu H, Ting DSJ, et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective[J]. Prog Retin Eye Res, 2021, 82: 100900. doi: 10.1016/j.preteyeres.2020.100900
[17]	Court JH, Austin MW. Virtual glaucoma clinics: patient acceptance and quality of patient education compared to standard clinics[J]. Clin Ophthalmol, 2015, 9: 745-749. http://www.dovepress.com/virtual-glaucoma-clinics-patient-acceptance-and-quality-of-patient-edu-peer-reviewed-article-OPTH
[18]	Odden JL, Khanna CL, Choo CM, et al. Telemedicine in long-term care of glaucoma patients[J]. J Telemed Telecare, 2020, 26: 92-99. doi: 10.1177/1357633X18797175
[19]	Gan K, Liu Y, Stagg B, et al. Telemedicine for Glaucoma: Guidelines and Recommendations[J]. Telemed J E Health, 2020, 26: 551-555. doi: 10.1089/tmj.2020.0009
[20]	Brady CJ, Garg S. Telemedicine for Age-Related Macular Degeneration[J]. Telemed J E Health, 2020, 26: 565-568. doi: 10.1089/tmj.2020.0011
[21]	Hwang DK, Hsu CC, Chang KJ, et al. Artificial intelligence-based decision-making for age-related macular degeneration[J]. Theranostics, 2019, 9: 232-245. doi: 10.7150/thno.28447
[22]	Li B, Powell AM, Hooper PL, et al. Prospective evalua-tion of teleophthalmology in screening and recurrence monitoring of neovascular age-related macular degeneration: a randomized clinical trial[J]. JAMA Ophthalmol, 2015, 133: 276-282. doi: 10.1001/jamaophthalmol.2014.5014
[23]	Wittenborn JS, Clemons T, Regillo C, et al. Economic Evaluation of a Home-Based Age-Related Macular Degenera-tion Monitoring System[J]. JAMA Ophthalmol, 2017, 135: 452-459. doi: 10.1001/jamaophthalmol.2017.0255
[24]	Acemoglu A, Peretti G, Trimarchi M, et al. Operating From a Distance: Robotic Vocal Cord 5G Telesurgery on a Cadaver[J]. Ann Intern Med, 2020, 173: 940-941. doi: 10.7326/M20-0418
[25]	Sachdeva N, Klopukh M, Clair RS, et al. Using conditional generative adversarial networks to reduce the effects of latency in robotic telesurgery[J]. J Robot Surg, 2021, 15: 635-641. doi: 10.1007/s11701-020-01149-5
[26]	Zheng J, Wang Y, Zhang J, et al. 5G ultra-remote robot-assisted laparoscopic surgery in China[J]. Surg Endosc, 2020, 34: 5172-5180. doi: 10.1007/s00464-020-07823-x
[27]	Chen H, Pan X, Yang J, et al. Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy[J]. JAMA Ophthalmol, 2021. doi: 10.1001/jamaophthalmol.2021.2312.
[28]	Annoh R, Patel S, Beck D, et al. Digital ophthalmology in Scotland: benefits to patient care and education[J]. Clin Ophthalmol, 2019, 13: 277-286. doi: 10.2147/OPTH.S185186
[29]	Tatham AJ, Ali AM, Hillier N. Knowledge of Glaucoma Among Patients Attending Virtual and Face-to-Face Glaucoma Clinics[J]. J Glaucoma, 2021, 30: 325-331. doi: 10.1097/IJG.0000000000001758
[30]	Patel AJ, Kloosterboer A, Yannuzzi NA, et al. Evaluation of the Content, Quality, and Readability of Patient Accessible Online Resources Regarding Cataracts[J]. Semin Ophthalmol, 2021, 36: 384-391. doi: 10.1080/08820538.2021.1893758
[31]	Chong JC, Tan CHN, Chen DZ. Teleophthalmology and its evolving role in a COVID-19 pandemic: A scoping review[J]. Ann Acad Med Singap, 2021, 50: 61-76. doi: 10.47102/annals-acadmedsg.2020459
[32]	Faes L, Rosenblatt A, Schwartz R, et al. Overcoming barriers of retinal care delivery during a pandemic-attitudes and drivers for the implementation of digital health: a global expert survey[J]. Br J Ophthalmol, 2020. doi: 10.1136/bjophthalmol-2020-316882.
[33]	Portney DS, Zhu Z, Chen EM, et al. COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses[J]. Ophthalmology, 2021. doi: 10.1016/j.ophtha.2021.02.010.
[34]	Bourdon H, Herbaut A, Trinh L, et al. An algorithm in ophthalmic emergencies to evaluate the necessity of physical consultation during COVID-19 lockdown in Paris: Experi-ence of the first 100 patients[J]. J Fr Ophtalmol, 2021, 44: 307-312. doi: 10.1016/j.jfo.2020.12.002
[35]	Ghazala FR, Hamilton R, Giardini ME, et al. Teleophthalmology techniques increase ophthalmic examination distance[J]. Eye(Lond), 2021, 6: 1780-1781. http://www.nature.com/articles/s41433-020-1085-8
[36]	Sommer AC, Blumenthal EZ. Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak[J]. Graefes Arch Clin Exp Ophthalmol, 2020, 258: 2341-2352. doi: 10.1007/s00417-020-04879-2
[37]	Rathi S, Tsui E, Mehta N, et al. The Current State of Teleophthalmology in the United States[J]. Ophthalmology, 2017, 124: 1729-1734. doi: 10.1016/j.ophtha.2017.05.026
[38]	Wildenbos GA, Peute L, Jaspers M. Aging barriers influencing mobile health usability for older adults: A literature based framework (MOLD-US)[J]. Int J Med Inform, 2018, 114: 66-75. doi: 10.1016/j.ijmedinf.2018.03.012
[39]	Gioia G, Salducci M. Medical and legal aspects of telemedicine in ophthalmology[J]. Rom J Ophthalmol, 2019, 63: 197-207. doi: 10.22336/rjo.2019.31